| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,410,000 | 3,887,000 | 6,049,000 | 2,399,000 | | Cost of Revenue | 387,000 | 474,000 | 546,000 | 333,000 | | | Gross Profit |
-
| 3,413,000 | 5,503,000 | 2,066,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,379,000 | 2,658,000 | 2,328,000 | 1,131,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 610,000 | 168,000 | 2,103,000 | 1,162,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 587,000 | 1,072,000 | (227,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,034,000 | 587,000 | 1,072,000 | (227,000) | | Interest Expense | 279,000 | 345,000 | 409,000 | 218,000 | | Income Before Tax | 755,000 | 242,000 | 663,000 | (445,000) | | Income Tax Expense | 196,000 | 35,000 | 133,000 | (197,000) | | Minority Interest | 20,000 | (13,000) |
-
|
-
| | | | Net Income From Continuing Ops | 579,000 | 194,000 | 530,000 | (248,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 579,000 | 194,000 | 530,000 | (248,000) | | Preferred Stock And Other Adjustments | (112,000) | (129,000) | (70,000) |
-
| | | Net Income Applicable To Common Shares | $467,000 | $65,000 | $460,000 | ($248,000) |
|
0.02% Nasdaq 
Income Statement
